About Mario Saltarelli
Form D filings for GABA Therapeutics in 2023 list Mario Saltarelli as chief executive officer and director.
Mario Saltarelli first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Mario Saltarelli in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mario Saltarelli works with at each company, as listed on that company's latest Form D.
GABA Therapeutics, Inc. · Form D, Oct 10, 2023
RB
Ryan Barrett
Director
HF
H. Fibiger
Director
SR
Srinivas Rao
Director
RF
Richard Farrell
Executive officer and director